Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Pharmaceutical

Idorsia

Jean-Paul Clozel

Nadia Riebel

Peter H.

Alice Matheron

Peter Rooney

Georg Rüedi

Eva Caroff

Antonio Olivieri

Julien Gander

Alberto Gimona

Alexander Khatuntsev

Martine Clozel

Olivier Lambert

André C. Muller

Andrew C. Weiss

Guy Braunstein

Markus A. Riederer

Leadership Team

Clinical Operations Team

Drug Discovery Team

Quality Assurance and Compliance Team

Marketing Management Team

Regulatory Affairs Team

��

Teams at Idorsia

Leadership Team

Clinical Operations Team

Drug Discovery Team

Quality Assurance and Compliance Team

Marketing Management Team

Regulatory Affairs Team

��������

Teams at Idorsia

Leadership Team

Clinical Operations Team

Drug Discovery Team

Quality Assurance and Compliance Team

Marketing Management Team

Regulatory Affairs Team

��